title: Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
abstract: DNA ploidy and the proliferative potential in 75 gliomas were investigated using bromodeoxyuridine labelling index (BrdUrd LI), S-phase fraction (SPF) and argyrophilic nucleolar organizer regions (AgNOR) technique. There were 53 highly malignant (AIII-AIV), and 22 low-grade (AI-AII) gliomas. One fragment of the tumour was fixed in Carnoy's solution for AgNOR test, while the other fragments were used for flow cytometric determination of the labelling index, SPF and DNA ploidy. For the BrdUrdLI, tumour samples from each patient were incubated in vitro for one hour at 37 degrees C with BrdUrd using the high pressure oxygen method. The tumours showed variability in the BrdUrdLI values, SPF and AgNOR counts/cell nucleus. The same percentage of DNA aneuploidy (55%) was found in high-grade as well as in low-grade gliomas. Univariate analysis showed that patients with grade I & II gliomas had significantly higher 3-year survival rate (p = 0.0193) than those with grade III and grade IV gliomas. Also patients with lower proliferation rate of tumours (BrdUrdLI < or =2.3% and AgNOR counts < or =2.6%/cell) had higher 3-year survival rate (p<0.03), which can be helpful in prognosis. Tumour ploidy or SPF had no influence on patients' survival (p = 0.7908). Cox multivariate analysis showed that only patients' age > 45 years and high tumour grade (III and IV) were significant unfavourable prognostic factors in terms of patients' survival.
authors.affiliation: Department of Radiation Oncology, Centre of Oncology, Kraków, Poland. z5gasins@cyf-kr.edu.pl
authors.forename: A
authors.initials: A
authors.lastname: Gasińska
authors.forename: T
authors.initials: T
authors.lastname: Krzyszk wski
authors.forename: J
authors.initials: J
authors.lastname: Niemiec
authors.forename: A
authors.initials: A
authors.lastname: Adamczyk
authors.forename: J
authors.initials: J
authors.lastname: Skołyszewski
mesh_terms: D000328:Adult; D000782:Aneuploidy; D001254:Astrocytoma / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D001932:Brain Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D001973:Bromodeoxyuridine / Q000378:metabolism; D002455:Cell Division; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009697:Nucleolus Organizer Region / Q000648:ultrastructure; D011003:Ploidies; D011379:Prognosis; D016196:S Phase; D016622:Silver Staining; D015996:Survival Rate
chemical_list: D004273:DNA, Neoplasm; D001973:Bromodeoxyuridine